Vnitr Lek 2019, 65(11):724-727 | DOI: 10.36290/vnl.2019.128

Vitamin D deficiency and its health effects

Pavel Horák
III. interní klinika -nefrologická, revmatologická, endokrinologická LF UP a FN Olomouc

Vitamin D3 cholecalciferol is produced from its cholesterol precursors in the skin under the influence of ultraviolet calc. Its subsequent hydroxylation in the liver and kidneys leads to the formation of its most active metabolite calcitriol, which plays one of the key roles in the management of calcium phosphate metabolism. However, it also has the ability to regulate the function of a number of cells and tissues that express the vitamin D receptor. The most widespread method to evaluate the status of vitamin D in the body is to measure serum levels of its metabolite 25 hydroxyvitamin D - 25 (OH) D. Optimal values range between 75-125 nmoll / l. Its deficit is widespread in the human population worldwide and has a significant impact on the prevalence of metabolic bone diseases. Its deficiency may support the dysfunction of many other body systems. Ensuring optimal levels of vitamin D in the population is a challenge not only for health care and especially for government administration.

Keywords: bone diseases; calciferol; calcium metabolism; deficiency; pleiotropic effect

Received: October 25, 2019; Published: November 1, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Horák P. Vitamin D deficiency and its health effects. Vnitr Lek. 2019;65(11):724-727. doi: 10.36290/vnl.2019.128.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Haussler MR. Vitamin D receptors: nature and function. Ann Revs Nutr 1986; 6: 527-562. Dostupné z DOI: <http://dx.doi.org/10.1146/annurev.nu.06.070186.002523>. Go to original source... Go to PubMed...
    2. Pavek P, Pospechova K, Svecova L et al. Intestinal cell-specific vitamin D receptor (VDR)-mediated transcriptional regulation of CYP3A4 gene. Biochem Pharmacol 2010; 79(2): 277-287. Dostupné z DOI: <http://dx.doi.org/10.1016/j.bcp.2009.08.017>. Go to original source... Go to PubMed...
    3. Adorini A, Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 2008; 4(8): 404-412. Dostupné z DOI: <http://dx.doi.org/10.1038/ncprheum0855>. Go to original source... Go to PubMed...
    4. Hart GR. Overview of vitamin D measurement and methodologies. Immunodiagnostic systems 2005; 2: 1-9.
    5. Pludowski P, Holick MF, Grant WB et al. Vitamin D supplementation guidelines. J Steroid Biochem Mol Biol 2018; 175: 125-135. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jsbmb.2017.01.021>. Go to original source... Go to PubMed...
    6. Vieth R, Cole DE, Hawker GA et al. Wintertime vitamin D insufficiency is common in young Canadian women, and their vitamin D intake does not prevent it. Eur J Clin Nutr 2001; 55(12): 1091-1097. Dostupné z DOI: <http://dx.doi.org/10.1038/sj.ejcn.1601275>. Go to original source... Go to PubMed...
    7. Välimäki VV, Alfthan H, Lehmusklallio E et al. Vitamin D status as a determinant of peak bone mass in young finnish men. J Clin Endocrinol Metabol 2004; 89(1): 76-80. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2003-030817>. Go to original source... Go to PubMed...
    8. Holick MF, Siris ES, Binkley N et al. Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005; 90(6): 3215-3224. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2004-2364>. Go to original source... Go to PubMed...
    9. Greene-Finestone LS, Berger C, de Groh M et al. 25-Hydroxyvitamin D in Canadian adults: biological, environmental, and behavioral correlates. Osteoporosis Int 2011; 22(5): 1389-1399. Dostupné z DOI: <http://dx.doi.org/10.1007/s00198-010-1362-7>. Go to original source... Go to PubMed...
    10. Pludowski P, Grant WB, Bhattoa HP et al. Vitamin D status in central Europe. Int J Endocrinol 2014; 2014:589587. doi: Dostupné z DOI: <http://dx.doi.org/10.1155/2014/589587>. Go to original source... Go to PubMed...
    11. Dort J, Bayer M, Dortová E et al. Vitamin D and other parameters of calcium and phosphate metabolism in healthy term newborns after birth. Osteol Bull 2007; 12(2): 70-73.
    12. Sochorová L, Hanzlíková L, Černá M et al. Assessment of vitamin D status in Czech children. Cent Eur J Public Health 2018; 26(4): 260-264. Dostupné z DOI: <http://dx.doi.org/10.21101/cejph.a5386>. Go to original source... Go to PubMed...
    13. Bischofova S, Dofkova M, Blahova J et al. Dietary Intake of Vitamin D in the Czech Population: A Comparison with Dietary Reference Values, Main Food Sources Identified by a Total Diet Study. Nutrients 2018; 10(10): pii: E1452. Dostupné z DOI: <http://dx.doi.org/10.3390/nu10101452>. Go to original source... Go to PubMed...
    14. Cashman KD, Dowling KG, Škrabáková Z et al. Vitamin D deficiency in Europe: pandemic? Am J Clin Nutr 2016; 103(4): 1033-1044. Dostupné z DOI: <http://dx.doi.org/10.3945/ajcn.115.120873>. Go to original source... Go to PubMed...
    15. Husain NE, Badie Suliman AA, Abdelrahman I et al. Vitamin D level and its determinants among Sudanese Women: Does it matter in a sunshine African Country? J Family Med Prim Care 2019; 8(7): 2389-2394. Dostupné z DOI: <http://dx.doi.org/10.4103/jfmpc.jfmpc_247_19>. Go to original source... Go to PubMed...
    16. Geusens P, van Brusel MS, Lems WF. Osteoporosis and fracture risk: pathogenesis, epidemiology, clinical aspects and diagnosis. In: Bijlsma JW (ed). Eular compendium on rheumatic diseases. BMJ Publishing: London 2009: 523-538. ISBN 978-1905545353.
    17. McKenna MJ. Differences in vitamin D status between countries in young adults and the elderly. Am J Med 1992; 93(1): 69-77. Dostupné z DOI: <http://dx.doi.org/10.1016/0002-9343(92)90682-2>. Go to original source... Go to PubMed...
    18. Krexner E, Resch H, Pietschmann P et al. Vitamin D status in residents of a long-term-care geriatric hospital in Vienna. Osteologie 1996; 5: 13-18.
    19. Chapuy MC, Durr F, Chapuy P. Age-related changes in parathyroid hormone and 25 hydroxycholecalciferol levels. J Gerontol 1996; 38(1): 19-22. Dostupné z DOI: <http://dx.doi.org/10.1093/geronj/38.1.19>. Go to original source... Go to PubMed...
    20. Cantorna MT, Mahon BD. D hormone and immune system. J Rheumatol Suppl 2005; 76: 11-20. Go to PubMed...
    21. Verhaar HJ, Samson MM, Jansen PAF et al. Muscle strength, functional mobility and vitamin D in older women. Aging (Milano) 2000; 12(6): 455-460. Go to original source... Go to PubMed...
    22. Judd S, Tangpricha V. Vitamin D Deficiency and Risk for Cardiovascular Disease. Am J Med Sci 2009; 338(1): 40-44. Dostupné z DOI: <http://dx.doi.org/10.1097/MAJ.0b013e3181aaee91>. Go to original source... Go to PubMed...
    23. Kheiri B, Abdalla A, Osman M et al. Vitamin D deficiency and risk of cardiovascular diseases: a narrative review. Clin Hypertension 2018; 24: 9. Dostupné z DOI: <http://dx.doi.org/10.1186/s40885-018-0094-4>. Go to original source... Go to PubMed...
    24. Skowron K, Pawlicka I, Gil K. The role of vitamin D in the pathogenesis of ocular diseases. Folia Med Cracov 2018; 58(2): 103-118. Dostupné z DOI: <http://dx.doi.org/10.24425/fmc.2018.124662>.
    25. Dankers W, Colin EM, van Hamburg JP et al. Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential Front Immunol 2016; 7: 697. Dostupné z DOI: <http://dx.doi.org/10.3389/fimmu.2016.00697>. Go to original source... Go to PubMed...
    26. Konduru M, Sastry KS, Fatima A et al. Vitamin D and the pathophysiology of inflammatory skin diseases. Skin Pharmacol Physiol 2018; 31(2): 74-86. Dostupné z DOI: <http://dx.doi.org/10.1159/000485132>. Go to original source... Go to PubMed...
    27. Rosa J, Šenk F, Palička V et al. Diagnostika a léčba postmenopauzální osteoporózy. Stanovisko Společnosti pro metabolická onemocnění skeletu ČLS JEP 2015. Osteol Bull 2015; 20(4): 150-168.
    28. Bouillon R, van Schoor NM, Gielen E et al. Optimal vitamin D status: a critical analysis on the basis of evidence-based medicine. J Clin Endocr Metab 2013; 98(8): E1283-304. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2013-1195>. Go to original source... Go to PubMed...
    29. Holick MF, Binkley NC, Bischoff-Ferrari HA et al. Evaluation, treatment, and preventiopn of vitamin D deficiency: an Endrocrine Society clinical practice quideline. J Clin Endocrinol Metab 2011; 96(7): 1911-1930. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2011-0385>. Go to original source... Go to PubMed...
    30. Bischoff-Ferrari HA, Shao A, Dawson-Hughes B et al. Benefit-Risk assessment of vitamin D supplemenation. Osteopos Int 2010; 21(7): 1121-1132. Dostupné z DOI: <http://dx.doi.org/10.1007/s00198-009-1119-3>. Go to original source... Go to PubMed...
    31. Kalvachová B. Vitamin D - nové poznatky a endokrinní mikrosystémy katcitriolu. Osteol Bull 2007; 12(2): 62-67.

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.